logo
Select company
Select metric
$ -63.42MConsolidated Income
VS
Market
17
Sector
32
Industry
30
History
14
$ 4.08Close
$ 1.96 - $ 4.24 52-Week Range
Ticker Information

Ticker

IMDX

Company Name

INSIGHT MOLECULAR DIAGNOSTICS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

INSIGHT MOLECULAR DIAGNOSTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IMDX - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -63.42M
3/31/2025$ -58.2M
12/31/2024$ -60.66M
9/30/2024$ -43.14M
6/30/2024$ -36.14M
3/31/2024$ -39.94M
12/31/2023$ -27.78M
9/30/2023$ -56.77M
6/30/2023$ -59.61M
3/31/2023$ -59.58M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INSIGHT MOLECULAR DIAGNOSTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -31.58M.
  • Over the past 5 years, INSIGHT MOLECULAR DIAGNOSTICS INC's average Cons. Inc. has been $ -49.72M.
  • The median Cons. Inc. for INSIGHT MOLECULAR DIAGNOSTICS INC during this period was $ -57.49M
  • INSIGHT MOLECULAR DIAGNOSTICS INC reached its highest Cons. Inc. over the past 5 years at $ -26.12M.
  • The lowest Cons. Inc. recorded by INSIGHT MOLECULAR DIAGNOSTICS INC in the same timeframe $ -72.9M

INSIGHT MOLECULAR DIAGNOSTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
VNRX : VOLITIONRX LTD $ -23.52MARMP : ARMATA PHARMACEUTICALS INC $ -25.71MCBUS : CIBUS INC $ -303.21MPYXS : PYXIS ONCOLOGY INC $ -96.29MNTRB : NUTRIBAND INC $ -10.27MPRPH : PROPHASE LABS INC $ -41.45MLUCD : LUCID DIAGNOSTICS INC $ -55.26MPSTV : PLUS THERAPEUTICS INC $ -19.03MBNBX : APPLIED DNA SCIENCES INC $ -13.3MALGS : ALIGOS THERAPEUTICS INC $ -74.18M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

IMDX - Consolidated Income, Last 5 years

$ -72.9M

Minimum

Dec 31, 2022

$ -26.12M

Maximum

Mar 31, 2021

$ -49.72M

Average

$ -57.49M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.08M with a standard deviation of $ 116.5M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.08M
median$ -2.07M
std$ 116.5M